Additionally, TGF-β has been shown to be a potent activator of stellate cells, the main precursor of CAFs in the liver [8,9,10], thereby promoting liver fibrosis [56], and these activated HSCs were shown to induce EMT and increase wound healing properties in HCC cells [21]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.